CAV1 Recombinant Monoclonal Antibody is a laboratory-engineered immunoglobulin produced using recombinant DNA technology. It specifically binds to human caveolin-1 (UniProt ID: Q03135), a 22 kDa protein encoded by the CAV1 gene (Entrez Gene ID: 857). This antibody reacts with human, mouse, and rat CAV1 isoforms, including both α and β forms, which are implicated in cancer metastasis and cellular signaling pathways .
Monoclonal antibodies against CAV1 have been generated using advanced methods, including:
Cav-1 knockout mice to preserve self-tolerance and enhance specificity .
Epitope-focused immunization targeting domains such as the N-terminus (amino acids 1–31), scaffolding domain (80–101), and C-terminal regions .
Key antibody groups identified:
Group | Binding Region | Number of Antibodies | Affinity (Kd) |
---|---|---|---|
N1-31 | N-terminus (1–31) | 5 | – M |
N32-80 | N-terminus (32–80) | 3 | – M |
CSD | Scaffolding Domain (80–101) | 2 | – M |
Cav-1-C | C-terminal half | 1 | M |
These antibodies recognize six distinct epitopes, enabling precise targeting of secreted CAV1 in cancer microenvironments .
In Prostate Cancer Models: Anti-CAV1 antibodies reduced tumor cell viability by 60–80% in DU145 and LNCaP cell lines .
Co-Immunoprecipitation Data: Both α and β CAV1 isoforms form multimeric complexes in cancer cell secretions, which are effectively neutralized by N1-31 and N32-80 group antibodies .
Serum Biomarker: Elevated CAV1 levels in patient serum predict poor prognosis .
Therapeutic Potential: Humanized monoclonal antibodies are under development for clinical trials .
CUSABIO's recombinant monoclonal antibody targeting CAV1 is generated through a robust process. Immunization of a rabbit with a synthesized peptide from human CAV1 initiates the process. B cells are isolated from the immunized rabbit, and RNA is extracted from these cells. This extracted RNA is then reverse-transcribed into cDNA, which serves as a template for extending CAV1 antibody genes using degenerate primers. These extended genes are introduced into a plasmid vector and transfected into host cells for expression. The CAV1 recombinant monoclonal antibody is purified from the cell culture supernatant through affinity chromatography and subjected to ELISA, WB, and FC applications. It exhibits specific reactivity with human CAV1 protein.
CAV1 is a structural protein that forms oligomers, creating caveolin complexes. These complexes are crucial for shaping and stabilizing caveolae on the cell membrane. Caveolae and CAV1 play significant roles in lipid transport and metabolism, particularly in regulating lipid droplet formation, lipid uptake, and cholesterol trafficking. CAV1 has been linked to various cellular responses to stress, including oxidative stress, mechanical stress, and cellular damage, potentially playing a protective role in some instances.